Ilaria Grisoni | Executive Director, Head of EU & International Pharmacovigilance, QPPV Office and EEA QPPV
Jazz Pharmaceuticals

Ilaria is currently Executive Director, Head of EU/International PV and QPPV Office at Jazz Pharmaceuticals. She also covers the role of EEA QPPV for Jazz. Ilaria is a member of the Global Regulatory Affairs & Drug Safety (GRADS) Leadership Team, as well as a member of the extended R&D Leadership Team at Jazz and leads the EU/International QPPV Office, ensuring PV oversight of affiliates and business partners in EU and International territories. She has more than 15 years of experience in the pharmaceutical industry, with extensive experience in Pharmacovigilance, including participation into several inspections by European and non-EU regulatory authorities. Ilaria is an active member of national and international PV working groups, including Farmindustria, Simef, PV Connect (Navitas Life Sciences), Raps (Regulatory Affairs Professionals Society), PIPA (she is the author of the PSMF Guidelines released in 2022) and DIA (she is a member of the organising committee for the Global QPPV Forum since 2025). She is a member of the Scientific Board of the Italian PV Day and participates as a speaker at conferences and seminars in the field of Pharmacovigilance.